ECM
AURA icon

ExodusPoint Capital Management’s Aura Biosciences AURA Stock Holding History

ExodusPoint Capital Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$120K Sell
17,955
-33,464
-65% -$192K ﹤0.01% 1426
2025
Q4 		$280K Buy
51,419
+7,998
+18% +$47.5K ﹤0.01% 1325
2025
Q3 		$268K Sell
43,421
-129
-0.3% -$844 ﹤0.01% 1329
2025
Q2 		$273K Buy
+43,550
New +$255K ﹤0.01% 1257

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ExodusPoint Capital Management's AURA Position: Q1 2026 in Review

ExodusPoint Capital Management reduced its Aura Biosciences (AURA) stake by 65% in Q1 2026, selling an estimated $192K and leaving 17,955 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #1426.

ExodusPoint Capital Management first reported a position in AURA in Q2 2025 and has held it in 4 quarters since. The position peaked at $280K in Q4 2025. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • ExodusPoint Capital Management held 17,955 shares of Aura Biosciences worth $120K as of Q1 2026.
  • ExodusPoint Capital Management sold 33,464 Aura Biosciences shares in Q1 2026, an estimated $192K.
  • Aura Biosciences made up ﹤0.01% of ExodusPoint Capital Management's portfolio in Q1 2026, its #1426 holding.
  • ExodusPoint Capital Management first reported a position in Aura Biosciences in Q2 2025 and has held it in 4 quarters since.
  • ExodusPoint Capital Management's Aura Biosciences position peaked at $280K in Q4 2025.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.